| | | KHELLIN
CAS:82-02-0
Formula: C14H12O5
ACM82020
260.24
2-g)(1)benzopyran-5-one,4,9-dimethoxy-7-methyl-5h-furo(;4,9-dimethoxy-7-methyl-5-oxo-1,8-dioxabenz-(f)indene;4,9-dimethoxy-7-methyl-5-oxofuro(3,2-g)(1)benzopyran;4,9-dimethoxy-7-methyl-5-oxofuro(3,2-g)-1,2-chromene;5,8-dimethoxy-2-methyl-4' KHELLIN
CAS:82-02-0
Formula: C14H12O5
ACM82020
260.24
2-g)(1)benzopyran-5-one,4,9-dimethoxy-7-methyl-5h-furo(;4,9-dimethoxy-7-methyl-5-oxo-1,8-dioxabenz-(f)indene;4,9-dimethoxy-7-methyl-5-oxofuro(3,2-g)(1)benzopyran;4,9-dimethoxy-7-methyl-5-oxofuro(3,2-g)-1,2-chromene;5,8-dimethoxy-2-methyl-4' KIFUNENSINE
CAS:109944-15-2
Formula: C8H12N2O6
ACM109944152
232.19
(5R,8aS)-1,5,6,7,8,8a-Hexahydro-6+¦,7+¦,8+¦-trihydroxy-5+¦-(hydroxymethyl)imidazo[1,2-a]pyridine-2,3-dione KIFUNENSINE
CAS:109944-15-2
Formula: C8H12N2O6
ACM109944152
232.19
(5R,8aS)-1,5,6,7,8,8a-Hexahydro-6+¦,7+¦,8+¦-trihydroxy-5+¦-(hydroxymethyl)imidazo[1,2-a]pyridine-2,3-dione KIFUNENSINE
CAS:109944-15-2
Trade Name: (5R,6R,7S,8R,8aS)-6,7,8-trihydroxy-5-(hydroxymethyl)-1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-2,
Formula: C8H12N2O6
APS109944152
232.19 KIFUNENSINE DIACETONIDE
CAS:134234-43-8
Formula: C14H20N2O6
ACM134234438-1
312.32
(3aS,3bR,7aR,11aS,11bR)-Hexahydro-2,2,5,5-tetramethyl-7H-[1,3]dioxino[4,5-e]-1,3-dioxolo[4,5-c]imidazo[1,2-a]pyridine-9,10-dione KIFUNENSINE DIACETONIDE
CAS:134234-43-8
Formula: C14H20N2O6
ACM134234438
312.32
(3aS,3bR,7aR,11aS,11bR)-Hexahydro-2,2,5,5-tetramethyl-7H-[1,3]dioxino[4,5-e]-1,3-dioxolo[4,5-c]imidazo[1,2-a]pyridine-9,10-dione KIR2DL1 Protein, Human, Recombinant (hFc)
RHC-CD-0517
51.7 kDa (predicted); 70 kDa (reducing condition,
XXbac-BPG184J6.7, XXbac-BCX195L8.1, p58.1, NKAT-1, NKAT1, NKAT, KIR-K64, KIR221, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1, CD158A KIR2DL1 Protein, Human, Recombinant (His & Avi)
RHC-CD-0401
27.1 kDa (predicted). Due to glycosylation, the pr
p58.1, NKAT-1, NKAT, KIR-K64, KIR2DL1/KIR2DS5, KIR2DL1, KIR221, cl-42, CD158Ankat1, CD158A KIR2DL1 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0417
27.1 kDa (predicted). Due to glycosylation, the pr
p58.1, NKAT-1, NKAT, KIR-K64, KIR2DL1/KIR2DS5, KIR2DL1, KIR221, cl-42, CD158Ankat1, CD158A KIR2DL1 Protein, Human, Recombinant (His)
RHC-CD-0691
26 kDa (predicted); 45 kDa (reducing condition, du
XXbac-BPG184J6.7, XXbac-BCX195L8.1, p58.1, NKAT-1, NKAT1, NKAT, KIR-K64, KIR221, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1, CD158A KIR2DL3 Protein, Human, Recombinant (hFc)
RHC-RP-2743
51.6 kDa (predicted)
p58, NKAT2B, NKAT2A, NKAT2, NKAT, MGC129943, KIR-K7c, KIR-K7b, KIRCL23, KIR2DS5, KIR-023GB, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3, GL183, CU464054.1, CD158B2, CD158b KIR2DL3 Protein, Human, Recombinant (His & Avi)
RHC-RP-2767
27.3 kDa (predicted). Due to glycosylation, the pr
NKAT2B, NKAT2A, NKAT-2, NKAT2, NKAT, KIR-K7c, KIR-K7b, KIRCL23, KIR2DS5, KIR2DL3, GL183, cl-6, CD158B2, CD158b KIR2DL3 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-2972
27.3 kDa (predicted). Due to glycosylation, the pr
NKAT2B, NKAT2A, NKAT-2, NKAT2, NKAT, KIR-K7c, KIR-K7b, KIRCL23, KIR2DS5, KIR2DL3, GL183, cl-6, CD158B2, CD158b KIR2DL3 Protein, Human, Recombinant (His)
RHC-RP-2630
25.9 kDa (predicted); 45 kDa (reducing condition,
p58, NKAT2B, NKAT2A, NKAT2, NKAT, MGC129943, KIR-K7c, KIR-K7b, KIRCL23, KIR2DS5, KIR-023GB, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3, GL183, CU464054.1, CD158B2, CD158b KIR2DL4 Protein, Human, Recombinant
RHC-CD-0573
25.1 kDa (predicted); 33-37 kDa (reducing conditio
KIR-2DL4, KIR2DL4, KIR-103AS, KIR103AS, KIR103, KIR, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4, G9P, CD158D KIR2DL4 Protein, Human, Recombinant (hFc)
RHC-CD-0516
51.3 kDa (predicted); 62, 34 and 32 kDa (reducing
KIR-2DL4, KIR2DL4, KIR-103AS, KIR103AS, KIR103, KIR, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4, G9P, CD158D KIR2DL4 Protein, Human, Recombinant (His)
RHC-CD-0408
30-40 kDa (reducing condition)
MHC Class I NK Cell Receptor KIR103AS, KIR2DL4, KIR-103AS, KIR103AS, Killer Cell Inhibitory Receptor 103AS, Killer Cell Immunoglobulin-Like Receptor 2DL4, G9P, CD158D, CD158 Antigen-Like Family Member D KIR2DL5 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-2739
26.3 kDa (predicted). Due to glycosylation, the pr
KIR2DL5B, KIR2DL5A, KIR2DL5.3, KIR2DL5.1, KIR2DL5, CD158F1, CD158F KIR3DL2 Protein, Human, Recombinant (His & Avi)
RHC-OTH-0032
37.9 kDa (predicted). Due to glycosylation, the pr
p140, NKAT4B, NKAT4A, NKAT-4, NKAT4, KIR3DL2, CL-5, CD158k KIRENOL
CAS:52659-56-0
Trade Name: (1R)-1-[(2S,4aR,4bS,6S,8R,8aS)-6-hydroxy-8-(hydroxymethyl)-2,4b,8-trimethyl-4,4a,5,6,7,8a,9,10-octah
Formula: C20H34O4
ACM52659560
338.5 Kirenol 100 -¦g/mL in Acetonitrile
CAS:52659-56-0
Trade Name: (1R)-1-[(2S,4aR,4bS,6S,8R,8aS)-6-hydroxy-8-(hydroxymethyl)-2,4b,8-trimethyl-4,4a,5,6,7,8a,9,10-octah
Formula: C20H34O4
APS52659560
338.48
(+¦7R,1R,3S,4aS,4bR,7S,10aS)-1,2,3,4,4a,4b,5,6,7,9,10,10a-Dodecahydro-3-hydroxy-+¦7-(hydroxymethyl)-1,4a,7-trimethyl-1,7-phenanthrenedimethanol, 1,7-Phenanthrenedimethanol, 1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-3-hydroxy-+¦7-(hydroxymethyl) KIZUTA SAPONIN K11
CAS:97240-03-4
Trade Name: [(2S,3R,4S,5S,6R)-6-[[(2R,4R,5S,6R)-6-(acetyloxymethyl)-3,4-dihydroxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trih
Formula: C61H98O27
ACM97240034
1263.3 KNG1 Protein, Human, Recombinant (His)
RHC-OTH-0181
61 kDa (reducing condition)
Williams-Fitzgerald-Flaujeac Factor, lpha-2-Thiol Proteinase Inhibitor, KNG1, KNG, Kininogen-1, HMWK, High Molecular Weight Kininogen, Fitzgerald Factor, BDK KOBOPHENOL A
CAS:124027-58-3
Formula: C56H44O13
PI124027583
924.9
[3,4'-Bibenzofuran]-6,6'-diol,3'-(3,5-dihydroxyphenyl)-4-[4-(3,5-dihydroxyphenyl)tetrahydro-2,5-bis(4-hydroxyphenyl)-3-furanyl]-2,2',3,3'-tetrahydro-2,2'-bis(4-hydroxyphenyl)-,[2S-[2+¦,3+¦[2R*,3R*(2'S*,3'S*)],4+¦,5+¦]]- KOBUSIN
CAS:36150-23-9
Trade Name: 5-[(3S,3aR,6S,6aR)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodi
Formula: C21H22O6
BBC36150239
370.40
(3a+¦,6a+¦)-1+¦-(3,4-Dimethoxyphenyl)-4+¦-(1,3-benzodioxole-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan KOBUSIN
CAS:36150-23-9
Trade Name: 5-[(3S,3aR,6S,6aR)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodi
Formula: C21H22O6
ACM36150239
370.40
(3a+¦,6a+¦)-1+¦-(3,4-Dimethoxyphenyl)-4+¦-(1,3-benzodioxole-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan KOBUSONE
CAS:24173-71-5
Trade Name: (1R,4R,6R,10S)-4,12,12-trimethyl-5-oxatricyclo[8.2.0.04,6]dodecan-9-one
Formula: C14H22O2
FFC-AR-24173715
222.32
(1R,4R,6R,10S)-4,12,12-Trimethyl-5-oxatricyclo[8.2.0.0sup4,6sup]dodecan-9-one KOHINOOL
CAS:81787-06-6
Formula: C12H26O
ACM81787066
186.33
2-HEPTANOL, 3,4,5,6,6-PENTAMETHYL;KOHINOOL;3,5,6,6-tetramethyl-4-methylene-2-heptano;3,5,6,6-tetramethyl-4-methylene-2-Heptanol;2-Heptanol, 3,5,6,6-tetramethyl-4-methylene- KOLAVENOL
CAS:19941-83-4
Trade Name: (E)-5-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-en
Formula: C20H34O
ACM19941834
290.49 KP 103
CAS:164650-44-6
Formula: C18H22F2N4O
PR164650446-1
348.39
(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;1-Piperidineethanol,+¦-(2,4-difluorophenyl)-+¦-methyl-4-methylene-+¦-(1H-1,2,4-triazol-1-ylmethyl)-,(+¦R,+¦R)-;(alphaR,betaR)-alpha-(2,4-Difluorophen KPNA2 Protein, Human, Recombinant (His)
RHC-OTH-0153
46-63 kDa (reducing condition)
SRP1-+¦, SRP1-Alpha, SRP1, RCH1, RAG Cohort Protein 1, KPNA2, Karyopherin Subunit +¦-2, Karyopherin Subunit Alpha-2, Importin Subunit +¦-2, Importin Subunit Alpha-2 KRAS Protein, Human, Recombinant (61Q, His)
RHC-ENZY-1977
21.9 kDa (predicted); 24.1 kDa (reducing condition
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRAS Protein, Human, Recombinant (G12D, His)
RHC-ENZY-1530
22 kDa (predicted)
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRAS Protein, Human, Recombinant (G12S, GST)
RHC-ENZY-1585
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRAS Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-ENZY-1811
23.78 kDa (predicted)
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRAS Protein,Human, Recombinant (Q61H, His)
RHC-ENZY-1824
22.5 kDa (predicted); 25 kDa (reducing conditions)
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRAS Protein,Human,Recombinant(G12C & Q61H, His)
RHC-ENZY-2144
23.3 kDa (predicted); 26.7 and 30.3 kDa (reducing
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRAS Protein,Human,Recombinant(G12D & Q61H, His)
RHC-ENZY-2345
23.3 kDa (predicted); 25.2 and 28.9 kDa (reducing
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2 KRESOXIM-METHYL
CAS:143390-89-0
Trade Name: methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate
Formula: C18H19NO4
APS143390890
313.35
Sovran, Discus, Stroby WG, Cygnus, Ergon (fungicide),Benzeneacetic acid, +¦-(methoxyimino)-2-[(2-methylphenoxy)methyl]-, methyl ester, (+¦E)-, Kresoxim-Me, Strob 1, Stroby DF, RIL-FA 200, BAS 490-02F, Kresoxim-methyl, Benzeneacetic acid, +¦-(m Kresoxim-methyl 10 -¦g/mL in Cyclohexane
CAS:143390-89-0
Trade Name: methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate
Formula: C18H19NO4
APS143390890A
313.35
Benzeneacetic acid, +¦-(methoxyimino)-2-[(2-methylphenoxy)methyl]-, methyl ester, (E)-, Ergon (fungicide), Stroby DF,Benzeneacetic acid, +¦-(methoxyimino)-2-[(2-methylphenoxy)methyl]-, methyl ester, (+¦E)-, Ergon, RIL-FA 200, Cygnus, Candit, B Kresoxim-methyl 1000 -¦g/mL in Acetone
CAS:143390-89-0
Trade Name: methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate
Formula: C18H19NO4
APS143390890B
313.35
Kresoxim-Me, Cygnus,Benzeneacetic acid, +¦-(methoxyimino)-2-[(2-methylphenoxy)methyl]-, methyl ester, (+¦E)-, Benzeneacetic acid, +¦-(methoxyimino)-2-[(2-methylphenoxy)methyl]-, methyl ester, (E)-, Ergon, RIL-FA 200, Candit, Discus (fungicide) KRYPTOFIX 22 DD
CAS:79495-97-9
Trade Name: 7,16-didecyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
Formula: C32H66N2O4
ACM79495979
542.88
Kryptofix 22dd, Kryptofix 22 DD, 36760_ALDRICH, 36760_FLUKA, MolPort-003-931-086, CID72806, EINECS 279-168-4, NSC339326, NSC 339326, NCGC00166067-01, 1,10-Didecyl-1,10-diaza-18-crown-6, 7,16-Didecyl-1,4,10,13-tetraoxa-7,16-diaza-cyclooctade KRYPTOFIX 222
CAS:23978-09-8
Formula: C18H36N2O6
ACM23978098
376.49
2,2,2-CRYPT;2,2,2-CRYPTAND;2,2,2-CRYPTATE;4,7,13,16,21,24-HEXAOXA-1,10-DIAZABICYCLO[8.8.8]HEXACOSANE;KRYPTAND 222;KRYPTOFIX 222;KRYPTOFIX(R) 222;CRYPTOFIX 222 KRYPTOFIX 222BB
CAS:40471-97-4
Formula: C26H36N2O6
ACM40471974
472.57
5,6,14,15-DIBENZO-4,7,13,16,21,24-HEXAOXA-1,10-DIAZABICYCLO[8.8.8]HEXACOSANE;KRYPTOFIX 222 BB;KRYPTOFIX(R) 222 BB;6,7,9,10,17,18,20,21-octahydro-8,19-(ethanoxyethanoxyethano)-8H,19H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazacyclooctadecine;K KRYPTOFIX 23
CAS:23978-10-1
Formula: C14H30N2O5
ACM23978101
306.4
KRYPTOFIX 23;KRYPTOFIX(R) 23;1,7,10,13,19-PENTAOXA-4,16-DIAZACYCLOHENEICOSANE;1,4,7,13,16-Pentaoxa-10,19-diazacycloheneicosane;1,4,7,13,16-pentaoxa-10,19-diazacyclo-heneicosane;1,4,7,13,16-pentaoxa-10,19-diazacyclohenicosane;1 4 7 13 16-PEN Kryptofix(R)211
CAS:31250-06-3
Formula: C14H28N2O4
ACM31250063
288.38
4,7,13,18-TETRAOXA-1,10-DIAZABICYCLO[8.5.5]EICOSANE;KRYPTOFIX 211;KRYPTOFIX(R) 211;4,7,13,18-tetraoxa-1,10-diazabicyclo[8.5.5]icosane;KRYPTOFIX 211 95+%;cryptating agent 211;[2.1.1]Cryptand;4,10-(Ethylenebisoxybisethylene)-1,7-dioxa-4,10-di Kryptofix(R)221
CAS:31364-42-8
Formula: C16H32N2O5
ACM31364428
332.44
KRYPTOFIX 221;KRYPTOFIX(R) 221;4,7,13,16,21-PENTAOXA-1,10-DIAZABICYCLO[8.8.5]TRICOSANE;4,7,16,21-Pentaoxa-1,10-diazabicyclo[8.8.5.]tricosane;4,7,13,16,21-pentaoxa-1,10-*diazabicyclo(8.8.5)tr;4,7,13,16,21-pentaoxa-1,10-diazabicylco-(8.8.5)tr KT 5720
CAS:108068-98-0
Formula: C32H31N3O5
NZs108068980
541.59
(9R,10S,12S)-2,3,9,10,11,12-Hexahyd ro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, hexyl ester KT 5823
CAS:126643-37-6
Formula: C29H25N3O5
NZs126643376
507.51
(9S,10R,12R)-2,3,9,10,11,12-Hexahyd ro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-dii ndolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodi azocine-10-carboxylic acid, methyl ester KU-0058948
CAS:763111-49-5
Trade Name: 4-[[3-(1,4-diazepane-1-carbonyl)-4-fluorophenyl]methyl]-2H-phthalazin-1-one
Formula: C21H21FN4O2
APS763111495
380.42
KU 0058958, KU 0058948,1(2H)-Phthalazinone, 4-[[4-fluoro-3-[(hexahydro-1H-1,4-diazepin-1-yl)carbonyl]phenyl]methyl]-, 1H-1,4-Diazepine, 1-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]hexahydro- (9CI), 4-[[4-Fluoro-3-[(hexah KUDINOSIDE D
CAS:173792-61-5
Trade Name: (1~{S},4~{S},5~{R},8~{R},10~{S},13~{S},14~{R},19~{S})-19-hydroxy-10-[(2~{S},3~{R},4~{S},5~{R})-5-hyd
Formula: C47H72O17
ACM173792615
909.07 KUGUACIN J
CAS:1141453-65-7
Trade Name: (3S,7S,8S,9R,10R,13R,14S,17R)-3,7-dihydroxy-4,4,13,14-tetramethyl-17-[(2R,4E)-6-methylhepta-4,6-dien
Formula: C30H46O3
ACM1141453657
454.7 KUGUACIN N
CAS:1141453-73-7
Trade Name: (3S,7S,8S,9R,10R,13R,14S,17R)-3,7-dihydroxy-4,4,13,14-tetramethyl-17-[(2R)-6-methyl-4-oxohept-5-en-2
Formula: C30H46O4
ACM1141453737
470.7 KUGUAGLYCOSIDE C
CAS:1041631-93-9
Trade Name: (3S,7S,8S,9R,10R,13R,14S,17R)-3-hydroxy-4,4,13,14-tetramethyl-17-[(2R,4E)-6-methylhepta-4,6-dien-2-y
Formula: C36H56O8
ACM1041631939
616.8 KULINONE
CAS:21688-61-9
Trade Name: (5R,9R,10R,13S,14S,16S,17S)-16-hydroxy-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2
Formula: C30H48O2
ACM21688619
440.70 KUWANON E
CAS:68401-05-8
Trade Name: (2S)-2-[5-[(2E)-3,7-dimethylocta-2,6-dienyl]-2,4-dihydroxyphenyl]-5,7-dihydroxy-2,3-dihydrochromen-4
Formula: C25H28O6
FFC-AR-68401058
424.5
5'-[(E)-3,7-Dimethyl-2,6-octadienyl]-2',4',5,7-tetrahydroxyflavanone L(-)-CARNITINE HYDROCHLORIDE, 98%
CAS:6645-46-1
Trade Name: [(2R)-3-carboxy-2-hydroxypropyl]-trimethylazanium;chloride
Formula: C7H16ClNO3
ACM6645461-1
197.66
r-3-carboxy-2-hydroxy-n,n,n-trimethylpropan-1-aminium chloride, l-carnitine hcl, unii-j3y5e6iks3, l-carnitine hydrochloride, levocarnitine chloride, j3y5e6iks3, r-carnitine hydrochloride, carnitine l-form hydrochloride, +--carnitine chlorid L(-)-SORBOSE
CAS:87-79-6
Trade Name: (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one
Formula: C6H12O6
BBC87796
180.16
1,3,4,5,6-pentahydroxyhexan-2-one L-(+)-CYSTATHIONINE
CAS:56-88-2
Trade Name: (2S)-2-amino-4-[(2R)-2-amino-2-carboxyethyl]sulfanylbutanoic acid
Formula: C7H14N2O4S
APS56882
222.26
S-[(2R)-2-Amino-2-carboxyethyl]-L-homocysteine, Butanoic acid, 2-amino-4-[(2-amino-2-carboxyethyl)thio]-, [R-(R*,S*)]-, S-[(2R)-2-Amino-2-carboxyethyl]-L-homocysteine, Cystathionine (6CI,7CI), L-Cystathionine, L-(+)-Cystathionine, L-Homocys L-(+)-ERGOTHIONEINE
CAS:497-30-3
Trade Name: (2S)-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)-2-(trimethylazaniumyl)propanoate
Formula: C9H15N3O2S
APS497303
229.30
2-Mercaptohistidine betaine, thiotaine,1H-Imidazole-4-ethanaminium, +¦-carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-, inner salt, (+¦S)-, Histidine, 2-mercapto-N,N-dimethyl-, betaine, 2-Mercapto-N,N-dimethylhistidine methyl ester betaine, Thi L-(-)-ARABITOL
CAS:7643-75-6
Trade Name: (2S,4S)-pentane-1,2,3,4,5-pentol
Formula: C5H12O5
FFC-AR-7643756
152.15
(2S,4S)-Pentane-1,2,3,4,5-pentaol L-(-)-GLUCOSE
CAS:921-60-8
Trade Name: (2S,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanal
Formula: C6H12O6
BBC921608
180.1
(2S,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanal L-(-)-GLUCOSE
CAS:921-60-8
Trade Name: (2S,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanal
Formula: C6H12O6
ACM921608
180.1
(2S,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanal L-+¦-Homo-+¦-(2,3-dimethoxyphenyl)glycine;(R)-3-Amino-3-(2,3-dimethoxyphenyl)propanoic acid
CAS:742691-70-9
Trade Name: (3R)-3-amino-3-(2,3-dimethoxyphenyl)propanoic acid
Formula: C11H15NO4
ACM742691709
225.25
742691-70-9, (R)-3-Amino-3-(2,3-dimethoxyphenyl)propanoic acid, (3R)-3-amino-3-(2,3-dimethoxyphenyl)propanoic acid, AG-G-95150, (R)-3-Amino-3-(2,3-dimethoxy-phenyl)-propionic acid, AC1MC5PY, SureCN12463711, CTK5D9645, H-D-b-Phe(2,3-dimethox L-+¦-Homo-+¦-(2,4,5-trifluorophenyl)alanine hydrochloride;(S)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride
CAS:1217809-78-3
Trade Name: (3S)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid;hydrochloride
Formula: C10H11ClF3NO2
ACM1217809783
269.65
(S)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride, 1217809-78-3, MolPort-003-794-889, AKOS015891146, AK119243, KB-211418, I01-9277, (S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTANOIC ACID HYDROCHLORIDE L-+¦-Homo-+¦-(2,4-dichlorophenyl)glycine;(R)-3-Amino-3-(2,4-dichlorophenyl)propanoic acid
CAS:778571-53-2
Trade Name: (3R)-3-amino-3-(2,4-dichlorophenyl)propanoic acid
Formula: C9H9Cl2NO2
ACM778571532
234.08
778571-53-2, (R)-3-Amino-3-(2,4-dichlorophenyl)propanoic acid, (3R)-3-amino-3-(2,4-dichlorophenyl)propanoic acid, AG-H-12060, (R)-3-Amino-3-(2,4-dichloro-phenyl)-propionic acid, AC1LE4NS, SureCN5721001, CTK5E5062, H-D-b-Phe(2,4-DiCl)-OH, Mo L-+¦-Phosphatidylinositol (Liver, Bovine) (sodium salt)
CAS:383907-33-3
Trade Name: Sodium;[(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-octadecanoyloxypropyl] [(5R)-2,3,4,
Formula: C47H82NaO13P
ACM383907333
909.1
Liver PI L-+¦-phosphatidylinositol (Soy) (sodiuM salt)
CAS:383907-36-6
Trade Name: Sodium;[(2S)-2,3-bis[[(9Z,12Z)-octadeca-9,12-dienoyl]oxy]propyl] [(2R,3R,5S,6R)-2,3,4,5,6-pentahydro
ACM383907366
866.65
Soy PI L-+¦-phosphatidylinositol-4-phosphate (Brain, Porcine) (aMMoniuM Salt)
CAS:475995-51-8
Trade Name: Diazanium;[(2S)-2,3,5,6-tetrahydroxy-4-[[(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-oc
ACM475995518
974.76
Brain PI(4)P |
